MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LAU, C.
Right arrow Articles by SLOTKIN, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LAU, C.
Right arrow Articles by SLOTKIN, T. A.

Molecular Pharmacology, Vol 18, 247-252, Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics

Regulation of Ornithine Decarboxylase Activity in the Developing Heart of Euthyroid or Hyperthyroid Rats

CHRISTOPHER LAU 1 and THEODORE A. SLOTKIN 1

1 Department of Pharmacology, Duke University Medical Center, Durham, North Carolina 27710

Ornithine decarboxylase (ODC), the rate-limiting enzyme in the biosynthesis of polyamines, displays high activity early in postnatal development of the heart, followed by a gradual decline to the low levels characteristic of adults. In both 2- and 4-day-old rat pups, kinetic studies revealed the presence of two distinctKmorn values of 50-60 and about 250 µM. However, by 7 days of age, only one form of the enzyme could be detected, with a Kmorn of 200-250 µM; after this point, the Kmorn remained at the low-affinity value, and further age-dependent reductions in activity occurred due to a progressive decline in the Vmax. The rate of disappearance of ODC activity, measured after the administration of cycloheximide, did not change with age. Neonatal administration of triiodothyronine (T3) evoked an initial elevation of ODC followed by depressed activity. As was true of controls, ODC from 2-day-old T3-treated rats displayed two separate kinetic forms, but the Vmax values of both forms were elevated above those of controls. At 10 days of age, only lowaffinity ODC could be found in T3-treated rats, and the Vmax was below that of controls. Cycloheximide treatment revealed only small changes in the half-life of ODC activity after T3 treatment. The accelerated maturational decline of cardiac ODC in hyperthyroid rats was correlated with depressed RNA synthesis and with subsequent deficits in heart weight. These results indicate that the developmental decline of heart ODC can be explained by the disappearance of the high-affinity kinetic form of the enzyme as well as by a reduction in enzyme synthesis and/or catalytic efficiency; after its initial stimulatory effect, neonatal hyperthyroidism exerts a deleterious effect on ODC activity which may contribute to deficient nucleic acid synthesis and cardiac growth.

Submitted on December 19, 1979
Accepted on May 2, 1980







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics